ZA882517B - Organic compounds and their use as pharmaceuticals - Google Patents

Organic compounds and their use as pharmaceuticals

Info

Publication number
ZA882517B
ZA882517B ZA882517A ZA882517A ZA882517B ZA 882517 B ZA882517 B ZA 882517B ZA 882517 A ZA882517 A ZA 882517A ZA 882517 A ZA882517 A ZA 882517A ZA 882517 B ZA882517 B ZA 882517B
Authority
ZA
South Africa
Prior art keywords
pharmaceuticals
organic compounds
compounds
organic
Prior art date
Application number
ZA882517A
Other languages
English (en)
Inventor
Maria Isabel Fernand Fernandez
Isabel Fernandez Fernand Maria
Terrence Michael Hotten
Michael Hotten Terrence
David Edward Tupper
Edward Tupper David
Original Assignee
Lilly Sa
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Sa, Lilly Industries Ltd filed Critical Lilly Sa
Publication of ZA882517B publication Critical patent/ZA882517B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA882517A 1987-04-13 1988-04-11 Organic compounds and their use as pharmaceuticals ZA882517B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878708833A GB8708833D0 (en) 1987-04-13 1987-04-13 Organic compounds

Publications (1)

Publication Number Publication Date
ZA882517B true ZA882517B (en) 1989-12-27

Family

ID=10615749

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882517A ZA882517B (en) 1987-04-13 1988-04-11 Organic compounds and their use as pharmaceuticals

Country Status (22)

Country Link
US (1) US4904686A (ko)
EP (1) EP0297697B1 (ko)
JP (1) JPS63267778A (ko)
KR (1) KR960011392B1 (ko)
CN (1) CN1025027C (ko)
AR (1) AR243886A1 (ko)
AT (1) ATE99308T1 (ko)
AU (1) AU622108B2 (ko)
CA (1) CA1333176C (ko)
DE (1) DE3886599T2 (ko)
DK (1) DK200588A (ko)
EG (1) EG18306A (ko)
GB (1) GB8708833D0 (ko)
HU (1) HU203546B (ko)
IE (1) IE61461B1 (ko)
IL (1) IL86031A (ko)
MX (1) MX174373B (ko)
NZ (1) NZ224195A (ko)
PH (1) PH24297A (ko)
PT (1) PT87209B (ko)
SU (1) SU1593572A3 (ko)
ZA (1) ZA882517B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0283380A (ja) * 1988-09-21 1990-03-23 Kotobuki Seiyaku Kk 新規ジアミン誘導体、抗不整脈剤及びその製法
GB8823041D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
GB8823040D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
GB8823042D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
CA2672776A1 (en) * 2006-12-20 2008-06-26 Novartis Ag 2-substituted 5-membered heterocycles as scd inhibitors
JP2022529663A (ja) * 2019-04-26 2022-06-23 ハー・ルンドベック・アクチエゼルスカベット Kv3カリウムチャネル活性化薬としてのアリールスルホニルチオフェンカルボキサミド及びアリールスルホニルフランカルボキサミド

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281394A (ko) * 1961-07-25
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
US3932503A (en) * 1966-05-28 1976-01-13 Hoechst Aktiengesellschaft Benzenesulfonyl ureas
DE1937759A1 (de) * 1967-08-12 1970-09-24 Hoechst Ag Benzolsulfonylsemicarbazide und Verfahren zu ihrer Herstellung
DE2500157C2 (de) * 1975-01-03 1983-09-15 Hoechst Ag, 6230 Frankfurt N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
US4123550A (en) * 1977-10-31 1978-10-31 Syntex (U.S.A.) Inc. Bicyclo[3.1.0]hexylethylaminocarbonyl-substituted heteroaryl cardiovascular agents
US4321378A (en) * 1979-01-16 1982-03-23 Delalande S.A. 8-(5-Pyrimidinecarboxamide)nor-tropane derivatives
SE8101536L (sv) * 1981-03-11 1982-09-12 Astra Laekemedel Ab Bensamid-derivat
DE3119796A1 (de) * 1981-05-19 1982-12-23 Hoechst Ag, 6000 Frankfurt Substituierte tryptaminderivate von thienyloxpropanolaminen, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen sowie ihre verwendung
DE3227329A1 (de) * 1982-07-22 1984-01-26 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 2-n,n-disubstituierten aminothiazolen
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
DE3529247A1 (de) * 1985-05-17 1986-11-20 Bayer Ag, 5090 Leverkusen Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
DE3609542A1 (de) * 1986-03-21 1987-10-01 Bayer Ag 5-acylamino-pyrazol-derivate

Also Published As

Publication number Publication date
DK200588D0 (da) 1988-04-12
PT87209A (pt) 1988-05-01
CN1025027C (zh) 1994-06-15
PT87209B (pt) 1992-07-31
DK200588A (da) 1988-10-14
EP0297697A1 (en) 1989-01-04
KR880012595A (ko) 1988-11-28
EP0297697B1 (en) 1993-12-29
MX11076A (es) 1993-09-01
KR960011392B1 (ko) 1996-08-22
PH24297A (en) 1990-05-29
AR243886A1 (es) 1993-09-30
MX174373B (es) 1994-05-11
DE3886599T2 (de) 1994-04-14
SU1593572A3 (ru) 1990-09-15
HU203546B (en) 1991-08-28
IL86031A (en) 1992-06-21
IE61461B1 (en) 1994-11-02
NZ224195A (en) 1990-06-26
EG18306A (en) 1992-10-30
CN1030916A (zh) 1989-02-08
DE3886599D1 (de) 1994-02-10
US4904686A (en) 1990-02-27
IL86031A0 (en) 1988-09-30
GB8708833D0 (en) 1987-05-20
CA1333176C (en) 1994-11-22
IE881085L (en) 1988-10-13
AU622108B2 (en) 1992-04-02
ATE99308T1 (de) 1994-01-15
HUT50324A (en) 1990-01-29
AU1450788A (en) 1988-10-13
JPS63267778A (ja) 1988-11-04

Similar Documents

Publication Publication Date Title
EG16349A (en) Novel organic compounds and their pharmaceutical use
IL88394A0 (en) Heterocyclic compounds and their use as insecticides
ZA896039B (en) Benzodiazepine compounds and their use as pharmaceuticals
ZA882517B (en) Organic compounds and their use as pharmaceuticals
ZA849677B (en) Organic compounds and their pharmaceutical use
EG16423A (en) Organic compounds and their pharmaceutical use
GB2151228B (en) Organic compounds and their pharmaceutical use
PH27529A (en) Organic compounds and their pharmaceutical use
GB8823043D0 (en) Organic compounds & their use as pharmaceuticals
GB8729170D0 (en) Organic composition
GB8703424D0 (en) Organic compounds
GB8700607D0 (en) Organic compounds
GB8703428D0 (en) Organic compounds
GB8703423D0 (en) Organic compounds
GB8702577D0 (en) Organic compounds
GB8702576D0 (en) Organic compounds
GB8702575D0 (en) Organic compounds
GB8702129D0 (en) Organic compounds
GB8702128D0 (en) Organic compounds
GB8701644D0 (en) Organic compounds
GB8701643D0 (en) Organic compounds
GB8701273D0 (en) Organic compounds
GB8701059D0 (en) Organic compounds
GB8703425D0 (en) Organic compounds
GB8706042D0 (en) Organic compounds